# Outpatient Discharge Therapy With Saxagliptin+MetforminXR vs GlipizideXL for Type 2 Diabetes With Severe Hyperglycemia

> **NCT01267448** · PHASE4 · COMPLETED · sponsor: **Cook County Health** · enrollment: 100 (estimated)

## Conditions studied

- Diabetes Mellitus Type 2
- Hyperglycemia

## Interventions

- **DRUG:** Glipizide XL
- **DRUG:** Saxagliptin + Metformin XR
- **DRUG:** Metformin XR

## Key facts

- **NCT ID:** NCT01267448
- **Lead sponsor:** Cook County Health
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-09-09
- **Primary completion:** 2015-07-25
- **Final completion:** 2015-07-25
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2023-06-26

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01267448

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01267448, "Outpatient Discharge Therapy With Saxagliptin+MetforminXR vs GlipizideXL for Type 2 Diabetes With Severe Hyperglycemia". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT01267448. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*